InvestorsHub Logo
Followers 52
Posts 3337
Boards Moderated 0
Alias Born 10/26/2013

Re: None

Tuesday, 06/30/2020 4:37:20 PM

Tuesday, June 30, 2020 4:37:20 PM

Post# of 3283
New Corporate Presentation posted last week.

They added 4 slides from the 'Poziotinib - Review Data and Program Strategy' and they added a bullet to a Rolontis slide

NCCN Guidelines recently revised to recommend increased use of G-CSF

are the major tweaks that I see.